Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal microdialysis after severe peritonitis
2012-004398-22Phase 4Completed
- Sponsor
- Odense University Hospital, Department of Hematology
- Start
- Apr 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meropenem, cefuroxime, piperacillin + tazobactam, metronidazole, fluconazole in peritonitis, secondary peritonitis, sponsored by Odense University Hospital, Department of Hematology. Started Apr 2013; status: completed.
02
Drugs
meropenemcefuroximepiperacillin + tazobactammetronidazolefluconazole
03
Conditions
peritonitissecondary peritonitis
Beyond the preview
Go deeper on 2012-004398-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004398-22.